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Two Imported 
Chikungunya 
Cases, Taiwan
To the Editor: Chikungunya is 
a reemerging infectious disease, en-
demic to Africa and Southeast Asia, 
caused by a mosquito-borne alphavi-
rus in the family Togaviridae. Numer-
ous chikungunya outbreaks have been 
reported in Africa and Southeast Asia 
since chikungunya virus (CHIKV) 
was ﬁ  rst isolated in Tanzania in 1953 
(1). Since 2005, several Indian Ocean 
islands and India have experienced 
massive CHIKV outbreaks caused by 
the East/Central/South African geno-
type (2,3), whereas all earlier isolates 
from India during 1963–1973 were of 
the Asian genotype (4). Other chikun-
gunya outbreaks caused by the Asian 
genotype were frequently reported 
during 1960–2003 in many Southeast 
Asian countries, including India, Ma-
laysia, Indonesia, Cambodia, Vietnam, 
Myanmar, Pakistan, the Philippines, 
and Thailand. Epidemics caused by 
reemerging CHIKV were reported in 
Indonesia and Malaysia during 2005–
2007 (1,5).
We have previously reported on 
fever screening at airports in Taiwan 
as part of active surveillance for a 
panel of notiﬁ  able infectious diseases 
such as dengue, gastroenteritis caused 
by enteric bacteria, malaria, and yel-
low fever (6). The activity is carried 
out by using infrared thermal scan-
ners to measure the body temperature 
of arriving passengers. Diagnostic 
testing algorithms for patients be-
ing screened for fever were based on 
evaluation by airport clinicians. The 
rationale behind this process is to 
minimize local outbreaks by reduc-
ing the number of imported cases. We 
report 2 imported chikungunya case-
patients identiﬁ  ed in Taiwan by fever 
screening at airports; 1 had returned 
from Singapore in 2006, infected with 
CHIKV East/Central/South African 
genotype, and the other had returned 
from Indonesia in 2007, infected with 
the Asian genotype.
To assess viremic fever patients 
with alphavirus infection, a multiplex 
1-step SYBR Green I-based real-time 
reverse transcription–PCR (RT-PCR) 
was developed. A cocktail consist-
ing of 3 sets of primers was mixed 
and used for RT-PCR screening. The 
alphavirus-speciﬁ  c primer set (AL-2: 
5′-AAG CTY CGC GTC CTT TAC 
CAA AG-3′ and AL-3: 5′-GTG GTG 
TCA AAC CCT ATC CA-3′) targeted 
a consensus region of the nonstruc-
tural protein 1 (nsp1) genes to detect 
all alphaviruses. The CHIKV-speciﬁ  c 
primer set (F-CHIK: 5′-AAG CTY 
CGC GTC CTT TAC CAA AG-3′ 
and R-CHIK: 5′-CCA AAT TGT 
CCY GGT CTT CCT-3′) targeted a 
region of the envelope protein 1 (E1) 
gene of CHIKVs (7). The Ross River 
virus–speciﬁ  c primer set (RRV-1: 5′-
GGG TAG AGA GAA GTT YGT 
GGT YAG-3′ and RRV-2: 5′-CGG 
TAT ATC TGG YGG TGT RTG C-3′) 
targeted a region of the envelope pro-
tein 2 (E2) gene of Ross River virus. 
Positive results were then conﬁ  rmed 
by gene sequence analysis, virus iso-
lation, and serologic tests. The nucle-
otide sequences of complete structural 
polyprotein genes were determined as 
previously described and submitted to 
GenBank (accession nos. EU192142 
and EU192143) (3,8). A phylogenetic 
tree, based on a total of 23 CHIKV 
partial E1 gene sequences (255 bp), 
was drawn to trace the origin of 2 
CHIKV isolates reported in this study 
(Figure).
The initial imported chikungunya 
case was detected at Taiwan Taoyuan 
International Airport on November, 
20, 2006, in a 13-year-old Taiwanese 
boy who was returning from studying 
at an international educational train-
ing center in Singapore. The second 
imported case was also detected at 
Taiwan Taoyuan International Airport 
on June, 20, 2007, in a 5-year-old boy 
on his return from visiting relatives in 
East Kalimantan Province, Indonesia, 
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with his mother. Both case-patients 
had fever, fatigue, generalized arth-
ralgia, and rash. Real-time RT-PCR 
screening showed a high level of al-
phavirus, but not ﬂ  avivirus,  viremia 
on day 2 (Singapore imported case) 
and day 3 (Indonesia imported case) 
acute-phase samples. Serodiagnosis 
with immunoﬂ  uorescent antibody as-
say (immunoglobulin M + G + A titers 
>640), and ELISA showed positive se-
roconversions for both patients.
Analysis showed that these 2 im-
ported cases were introduced from 
Singapore and Indonesia and that the 
patients were infected with CHIKV of 
East/Central/South African genotype 
and Asian genotype, respectively. Un-
like dengue, chikungunya is not en-
demic to Singapore. However, a small 
chikungunya outbreak caused by an 
Indian strain of East/Central/South Af-
rican genotype transmitted by Aedes 
aegypti was reported in January 2008; 
this occurrence suggests that imported 
CHIKV may not be detected because 
of limited transmission and because 
the signs and symptoms may be mis-
taken for those of dengue (9). In con-
trast, chikungunya has been endemic 
to Indonesia since 1973. Indonesia had 
epidemic outbreaks in 1980, 1983–
1984, and yearly outbreaks after 1998. 
In following the ongoing chikungunya 
epidemic, we have identiﬁ   ed 4 ad-
ditional imported chikungunya cases 
from Indonesia since July 2007.
A recent chikungunya outbreak 
in Italy demonstrated that Aedes al-
bopictus is a competent vector that 
can initiate local transmission of im-
ported CHIKV (10). In Taiwan, Ae. 
albopictus is distributed throughout 
the island, and Ae. aegypti is distrib-
uted only in southern Taiwan. With in-
creasing numbers of imported CHIKV 
infections, the risk for local transmis-
sion is similar to that of dengue, espe-
cially in southern Taiwan. Our results 
show that CHIKVs of both genotypes 
are spreading in Southeast Asia. The 
cocirculation of dengue and chikungu-
nya would likely be increased in many 
Southeast Asian and African countries 
because of the rise in international 
travel and the wide distribution of the 
competent vectors, Ae. albopictus and 
Ae. aegypti.
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Figure. Phylogenetic relationships of chikungunya virus (CHIKV) isolates from 2 imported 
cases in Taiwan. The tree was constructed by the neighbor-joining method using partial 
nucleotide sequences of envelope protein 1 (E1) gene (255 bp) of 23 CHIKV strains. 
O’nyong-nyong (ONN) virus sequence was used as the outgroup virus. Bootstrap support 
values >75 are shown. The 2 imported CHIKV strains in Taiwan are designated by boldface 
type. Viruses were identiﬁ   ed by using the nomenclature of virus/country/strain/year of 
isolation/GenBank accession no. Scale bar indicates substitutions per site.
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Chikungunya-
related Fatality 
Rates, Mauritius, 
India, and 
Reunion Island 
To the Editor: During the epi-
demic of chikungunya virus infection 
that occurred on Reunion Island in 
2005–06, we reported an overmor-
tality corresponding to the epidemic 
peak, which was estimated by compar-
ing observed and expected deaths (1). 
The excess was similar to the number 
of deaths related to chikungunya in-
fection reported by death certiﬁ  cates 
(2). The case-fatality rate (CFR) on 
Reunion Island was estimated to be 
1/1,000 population.
According to Beesoon et al. (3), 
the fatality rate attributable to chikun-
gunya infection was much higher on 
Mauritius: 743 deaths in excess of ex-
pected deaths led to a CFR of ≈4.5%, 
with 15,760 conﬁ   rmed or suspected 
cases for 2005 and 2006 as reported in 
this letter. A similar CFR of 4.9% can 
be calculated for the city of Ahmeda-
bad, India, during the 2006 chikungu-
nya epidemic (4).
This 45- to 49-fold difference 
could be explained by a greater sever-
ity of chikungunya infection in Mau-
ritius or Ahmedabad that could be due 
to a mutating strain, differences in 
the preexisting conditions of patients, 
differences in the management of pa-
tients, or by coincident deaths in ex-
cess from other causes.
However, the most probable ex-
planation can be attributed to the sur-
veillance systems of chikungunya cas-
es. On Reunion Island, surveillance 
was highly sensitive and relied either 
on active case ﬁ  nding or on estimates 
of suspected cases. Results have been 
assessed by iterative external stud-
ies and serosurveys, and the CFR we 
found is likely consistent.
If we apply this rate to Mauritius, 
≈60% of the population would have 
contracted chikungunya infection dur-
ing this epidemic. If so, the risk of 
epidemic resurgence could be much 
lower than previously expected. This 
point raises the need to conduct sero-
prevalence studies in those territories, 
the only way to evaluate the herd im-
munity level of the population.
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Aquaculture and 
Florfenicol 
Resistance in 
Salmonella enterica 
Typhimurium DT104
To the Editor: In June 2006, the 
World Health Organization (WHO), 
the Food and Agriculture Organiza-
tion of the United Nations (FAO), 
and the World Organisation for Ani-
mal Health (OIE) convened an Expert 
Consultation to consider the risks to 
human health represented by the use 
of antimicrobial drugs in aquaculture. 
This would, therefore, appear to be 
an opportune time to reexamine some 
of the arguments that have been pre-
sented with respect to the assessment 
of these risks.
In their contributions to the de-
bate regarding the risks associated 
with the use of antimicrobial agents in 
aquaculture, Angulo (1), Angulo and 
Grifﬁ  n (2), Ribot et al. (3), and, more 
recently, Cabello (4) have argued that 
the available molecular evidence sug-
gests that the ﬂ  o gene that encodes 
chloramphenicol and ﬂ  orfenicol resis-
tance in Salmonella enterica serovar 
Typhimurium DT104 (DT104) origi-
nally emerged in Japanese aquaculture 
and may have transferred horizontally 
from this host to DT104. This argu-
ment also appears in the report of the 
WHO/FAO/OIE consultation (ftp://
ftp.fao.org/ag/agn/food/aquaculture_
rep_13_16june2006.pdf). These au-
thors (1–4) have based their argument 
on the assertions that ﬂ  orfenicol was 
ﬁ  rst used in Japan and that ﬂ  o gene–
mediated resistance to this agent was 
ﬁ  rst identiﬁ  ed in bacteria isolated from 
Japanese ﬁ  sh farms.
In attempting to identify the date 
of the emergence of ﬂ  orfenicol resis-
tance in Japanese aquaculture, Angu-
lo and Grifﬁ  n (2) state that ﬂ  orfenicol 
had been used in this country since 
the early 1980s. However, Scher-
ing Plough, the manufacturer of ﬂ  o-
rfenicol, reports ﬁ  rst marketing this 
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